Research Paper

Pdf file on Synergy

omments

Acta Biochim Biophys Sin 2005,37:688-693

doi:10.1111/j.1745-7270.2005.00098.x

Nitric Oxide Inducing Function and Intracellular Movement of Chicken Interleukin-18 in Cultured Cells

 

Jian XU1,3, Tong-Le DENG2, Long LI1, Zhen-Qiang YOU1, Wang-Jun WAN2, and Lian YU1*

 

1 Zhejiang Provincial Key Laboratory of Preventive Veterinary Medicine, Institute of Preventive Veterinary Medicine,

Zhejiang University, Hangzhou 310029, China;

2 College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou 310029, China;

3 Medical College of Shihezi University, Xinjiang 832002, China

 

Received: June 23, 2005

Accepted: July 15, 2005

This work was supported by the grants from the National High Technology Research and Development Program of China (No. 101-j99-02) and the Key Project of Zhejiang Province (No. 011102465)

*Correspondence author: Tel/Fax, 86-571-86971894; E-mail, yulian@zju.edu.cn

 

Abstract        To evaluate the characteristics of chicken interleukin-18 (ChIL-18) in different forms in vitro, the ChIL-18 full-length gene (ChIL-18-F) and the ChIL-18 presumed mature protein gene (ChIL-18-M) were cloned and inserted into the eukaryotic expression vector pCI, to construct recombinant pCI-ChIL-18-F and pCI-ChIL-18-M. The recombinant plasmids were then transferred into chicken splenic lymphocytes(CSLs). Western blot showed that ChIL-18-F, with a molecular weight of 23.0 kDa, was produced in CSLs transfected by pCI-ChIL-18-F; ChIL-18-M, with a molecular weight of 19.5 kDa, was produced in CSLs transfected by pCI-ChIL-18-M. The nitric oxide (NO) level in the transfected CSLs and the culture medium at different time points was further examined under confocal microscopy using 4,5-diaminofluorescein staining. The results showed that both pCI-ChIL-18-F and pCI-ChIL-18-M groups showed significant increase in intracellular and extracellular NO production compared with pCI transfected control cells. These results suggest that both ChIL-18-F and ChIL-18-M could stimulate NO secretion in CSLs. To characterize the intracellular distribution of ChIL-18, ChIL-18-F and ChIL-18-M were each fused to the enhanced green fluorescent protein gene, and expressed in Vero cells. The results showed that the ChIL-18-F tended to the membranous region in Vero cells, while ChIL-18-M did not. This indicates that the N-terminal 27 amino acid peptide helped ChIL-18 target to Vero cell membranes.

 

Key words        chicken interleukin-18; N-terminal peptide; nitric oxide; splenic lymphocyte; intracellular movement

 

The interleukin-18 gene (IL-18) was first cloned from propioibacteriumacnes-treated and lipopolysaccharide-treated mouse livers in 1995 by Okamura et al. [1]. In mammals, IL-18 is a pro-inflammatory cytokine with ­biological properties similar to those of IL-12. It acts in synergy with IL-12 to promote the production of Th1 cells [2]. As a member of the IL-1 family, the mammalian IL-18 was originally described as an interferon-g (IFN-g) ­inducing factor [3,4]. Other functions of IL-18 include the induction of IL-1b and tumor necrosis factor-a, the enhancement of natural killer cell cytotoxicity and ­neutrophil activity, as well as the enhancement of Fas ligand expression of Th1 cells [5,6]. As IL-1b, IL-18 is ­synthesized as a precursor molecule with a typical signal peptide and is cleaved by caspase-1, an intracellular ­protease, into an active cytokine [7]. Although mammalian­ IL-18 has been described in many materials, the study of ovipara IL-18 was very limited.

The chicken IL-18 gene (ChIL-18) was first cloned from the chicken macrophage cell line HD-11 in 2000 by Schneider et al. [8]. ChIL-18 can regulate IFN-g expression­ in T cells [9,10], which upregulates the ­expression of MHC class I molecules, activates macrophages, and stimulates the secretion of nitrogen intermediates, such as nitric oxide (NO) [11]. The ­production of NO was ­always used to measure IFN-g activity, which showed the activity of IL-18. One clone strategy for ChIL-18 from Xiaoshan chicken, a local ­Chinese breed, was established in our laboratory. The ChIL-18 full-length gene (ChIL-18-F) was amplified from splenic lymphocytes stimulated with lipopolysaccharide (GenBank accession No. AY628648). The full-length cDNA of Xiaoshan chicken IL-18 consists of 591 bp and contains the complete open reading frame (ORF). Sequence ­comparisons revealed that the critical aspartate residue is conserved in ChIL-18, indicating that ChIL-18 may also be cleaved at this residue. Presumed mature ChIL-18 (ChIL-18-M) thus consists of 169 amino acid residues [8].

Human IL-18 was confirmed to be synthesized as a biological inactive precursor (pro-IL-18), which is cleaved by caspase-1 to form a mature cytokine with biological activities [12]. Schneider et al. have also shown that the recombinant ChIL-18-M expressed in bacteria can induce IFN-g synthesis in primary cultured chicken spleen cells [8]. Puechler et al. have described a sensitive bioassay that is based on ChIL-18 inducing the release of IFN-g in a permanent chicken cell line [13]. But there is no report about the eukaryotic expression of ChIL-18-F or ChIL-18-M, nor the NO secretion induction. It is not known whether ChIL-18-F is biologically active, or whether it is converted into ChIL-18-M through the action of caspase-1 in chicken splenic lymphocytes (CSLs).

In this report, the characteristics of ChIL-18-F and ChIL-18-M were analyzed in CSLs. NO secretion was used to evaluate the activities of ChIL-18-F and N-­terminal truncated ChIL-18-M. The effects of N-terminal 27 amino acid peptide (NP) on the distribution and subcellular ­tropism of ChIL-18 were further traced by enhanced green fluorescent protein (EGFP) in Vero cells.

 

 

Materials and Methods

 

Plasmids and cell culture

 

Eukaryotic expression vector pCI was purchased from Promega (San Luis Obispo, USA). pT-ChIL-18-F ­containing the complete ORF of Xiaoshan chicken IL-18 was constructed in our laboratory. Vero cells were ­cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Gaithersburg, USA) supplemented with 5% fetal bovine ­serum (FBS; Gibco), 100 IU/ml penicillin and 100 mg/ml streptomycin­ at 37 ºC with 5% CO2.

Construction of recombinant eukaryotic expression plasmids

 

Assuming that the Xiaoshan ChIL-18-F protein is cleaved at the 27th amino acid residue after the conserved ­aspartate residue, we used polymerase chain reaction (PCR) to amplify a cDNA fragment encoding an N-terminal ­truncated form of ChIL-18. The ORF of ChIL-18-F and ChIL-18-M were amplified with primer pairs P1/P2 and P3/P2 (Table 1) from pT-ChIL-18-F respectively. The PCR fragments were each inserted into pCI after ­digestion with restriction enzymes, resulting in pCI-ChIL-18-F (containing the complete ORF of ChIL-18, ChIL-18-F) and pCI-ChIL-18-M (containing ChIL-18-M).

In another independent experiment, the ORF of ChIL-18-F and ChIL-18-M were amplified by primer pairs P1/P4 and P3/P4 respectively (Table 1). The two fragments were cloned into pEGFP-N1 vector (Clontech, Palo Alto, USA), producing pChIL-18-F-EGFP and pChIL-18-M-EGFP.

 

Transfection of ChIL-18 with or without NP coding sequence into CSLs

 

The CSLs were aseptically isolated from 5-week old specific pathogen free chickens [14], and cultured in RPMI 1640 (HyClone, Logan, USA) supplemented with 5% FBS, 100 IU/ml penicillin and 100 mg/ml streptomycin at 37 ºC with 5% CO2. After 48 h, the CSLs were centrifugated at 1500 g for 10 min, and plated at 1´107 cells/ml in growth medium without antibiotics. The plasmids pCI-ChIL-18-F and pCI-ChIL-18-M were transferred into resuspended CSLs using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) as previously described [15].

 

NO secretion measurement

 

The transfected CSLs and culture media were collected at different time points for NO production analysis [16]. NO in transfected cells was observed under laser ­confocal microscopy 510 (Zeiss, Oberkochen, Germany) after ­staining with 4,5-diaminofluorescein (DAF-2). The nitrate reduction test was used to determine NO secretion with an NO testing kit (Institute of Jiancheng Biological Engineering, Nanjing, China) [17].

 

Recombinant ChIL-18 expression analysis

 

The transcriptions of target genes were determined by reverse transcription (RT)-PCR with primers P3 and P4 using the total RNA extracted from cells 24 h after ­transfection as the template. At different post-transfection time points, the cells were collected, alternately frozen and thawed three times, and centrifugated at 8000 g. The ­supernatant was collected. Western blot and enzyme-linked immunosorbent assay (ELISA) were carried out to ­determine protein expression, with rabbit anti-ChIL-18 serum as the primary antibody and horseradish peroxidase­ conjugated goat anti-rabbit IgG (Invitrogen) as the ­secondary antibody. The ChIL-18 antiserum was prepared in our laboratory from New Zealand white rabbits ­immunized with recombinant ChIL-18 protein expressed in Escherichia coli. The titer of the antibody was up to    1:12,800.

 

Subcellular tropism of recombinant ChIL-18 with or without NP in Vero cells

 

After the Vero cells were transfected with pChIL-18-F-EGFP or pChIL-18-M-EGFP, they were examined under laser confocal microscopy 510 for EGFP localization.

 

 

Results

 

NO secretion induced by recombinant ChIL-18

 

NO secretion in the transfected cells was observed ­under confocal microscopy 510 by staining with DAF-2, a high sensitivity fluorescent probe that can pass through the cellular membrane and shows a fluorescent loop after association with NO. Fig. 1 shows that a small number of CSLs displayed fluorescence 3 h post-transfection, and the cell number increased 24 h post-transfection.

NO secretion in the transfected cells and the culture medium was studied further. As shown in Figs. 2 and 3, NO levels significantly increased in the pCI-ChIL-18-F and pCI-ChIL-18-M transfection groups compared with the pCI control, both in the cells and in the culture medium. NO levels peaked in the cells and the medium 24 h post-transfection. The NO production curve of both cultured cells and culture medium had a similar trend, except for cell samples 3 h and 9 h post-transfection. The results suggested that both ChIL-18-F and ChIL-18-M had the ability to induce NO secretion.

 

Recombinant ChIL-18 expression in CSLs

 

One fragment of DNA of approximately 500 bp was ­amplified by RT-PCR from each test group 24 h after ­transfection (data not shown). Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and ­Western blot analysis could also detect specific protein bands (23.0 kDa for ChIL-18-F and 19.5 kDa for ChIL-18-M) at the same time point (Fig. 4). Only the band of 23.0 kDa could be seen in ChIL-18-F gene transfected CSLs, which suggested that the N-terminal 27 amino acid peptide of ChIL-18-F was not cleaved in CSLs. ChIL-18-F itself was biologically active.

To further examine the expression of ChIL-18-F and ChIL-18-M, the protein outputs at different time points were determined by ELISA. There was no significant ­difference on the expression between ChIL-18-F and ChIL-18-M (P>0.05). These results showed that ChIL-18-F and ChIL-18-M were both expressed in CSLs.

 

Expression and localization of recombinant ChIL-18-EGFP

 

To further investigate the intracellular localization of ChIL-18-F and ChIL-18-M, pChIL-18-F-EGFP and pChIL-18-M-EGFP were transfected into Vero cells. The fused proteins were expressed and observed by laser confocal microscopy 510 (Fig. 5). The transfected cells presented a diffusing and uniform fluorescence throughout the ­cytoplasm and nucleus 10 h post-transfection [Fig. 5(A-C)]. No specific intracellular targeting of the fluorescence was observed, and no accumulation occurred in the membranous region or in the peripheral vesicles. The results showed that ChIL-18 fused to EGFP with or without leader peptide was expressed in Vero cells. However, the ­distribution of fluorescence in the cells transfected with pChIL-18-F-EGFP was different to that produced in the cells ­transfected with pChIL-18-M-EGFP 24 h post-transfection. The fluorescence of ChIL-18-F appeared to clearly target to the membranous region of the Vero cells [Fig. 5(F)], but ChIL-18-M and EGFP did not [Fig. 5(D,E)]. This indicated that the N-terminal 27 amino acid ­peptide induced the intracellular movement of ChIL-18 from the cytoplasm and the nucleus to the membrane.

 

 

Discussion

 

In this work, the NO inducing ability of Xiaoshan ChIL-18-F and ChIL-18-M was determined. Our results also demonstrated that ChIL-18-F and ChIL-18-M are both active in NO induction (P<0.05). Although the full-length gene could help the expression of ChIL-18 in CSLs, there was no statistical difference in the expression level of ChIL-18-F and ChIL-18-M (P>0.05). These results indicated that the higher NO output might be related to the ­magnification effects of expression. On the other hand, as Fig. 5 showed, the N-terminal 27 amino acid peptide of ChIL-18 was involved in ChIL-18 targeting the membrane­ of Vero cells. These results suggest that the N-terminal 27 amino acid peptide of ChIL-18 could combine­ to some membrane proteins of Vero cells.

As the proteins were expressed under the control of same promoter, the corresponding mRNAs should be ­produced at the same rate, as determined using ChIL-18-specific RT-PCR (data no shown). However, time-­dependent fluorescence decrease was observed in cells transfected with pChIL-18-F-EGFP or pChIL-18-M-EGFP compared with those transfected with pEGFP-N1. There are several possible reasons: (1) the ChIL-18-EGFP ­fusion protein is somewhat unstable in Vero cells and might be rapidly degraded; (2) the Vero cell system might not be suitable for efficient expression of ChIL-18; or (3) there are multiple influencing factors for eukaryotic expression systems.

Both mammalian pro-IL-18 and ChIL-18 lack a signal peptide that usually directs proteins to the secretory ­apparatus of cells. Molecular mechanisms of the release of these two proteins are assumed to be very similar but are not completely understood yet [18]. In this work, we found that ChIL-18 enhances the NO secretion in ­transfected CSLs, which suggests the increase of IFN-g output; the intracellular movements of recombinant ChIL-18-F and ChIL-18-M were different, which indicated that the N-terminal 27 amino acid peptide targeted ChIL-18 to the membrane of Vero cells; and ChIL-18-F showed ­similar functions to ChIL-18-M, which are different to ­mammalian IL-18. This work provides new facets to the previous description of ChIL-18.

 

 

Acknowledgements

 

We thank Prof. Xiao-Xiang ZHENG (Zhejiang University, Hangzhou, China) and Prof. Wei-Huan FANG (Zhejiang University, Hangzhou, China) for their kind help with the confocal micrograph technique.

 

 

References

 

1    Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Haruka A, Tanimoto T, Torigoe K et al. Cloning of a new cytokine that induces IFN-g production by T cells. Nature 1995, 378: 88-91

2    Kaiser P. Turkey and chicken interleukin-18 (IL-18) share high sequence identity, but have different polyadenylation sites in their 3' UTR. Dev Comp Immunol 2002, 26: 681-687

3    Steele T. Clinical significance of interleukin-18. Leuk Res 2002, 26: 975-976

4    Dinarello CA, Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis 2003, 187: 370-384

5    Puren AJ, Fantuzzi G, Dinarello CA. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1b are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA 1999, 96: 2256-2261

6    Taniguchi M, Nagaoka K, Ushio S, Nukada Y, Okura T, Mori T, Yamauchi H et al. Establishment of the cells useful for murine interleukin-18 bioassay by introducing murine interleukin-18 receptor cDNA into human myelomonocytic KG-1 cells. J Immunol Methods 1998, 217: 97-102

 7   Tringali G, Pozzoli G, Vairano M, Mores N, Preziosi P, Navarra P. Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis. J Neuroimmunol 2005, 160: 61-67

 8   Schneider K, Puehler F, Baeuerle D, Elvers S, Staeheli P, Kaspers B, Weining KC. cDNA cloning of biologically active chicken interleukin-18. J Interferon Cytokine Res 2002, 20: 879-883

 9   Kogut MH, Rothwell L, Kaiser P. Priming by recombinant chicken interleukin-2 induces selective expression of IL-8 and IL-18 mRNA in chicken heterophils during receptor-mediated phagocytosis of opsonized and nonopsonized Salmonella enterica serovar enteritidis. Mol Immunol 2003, 40: 603-610

10  Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-g production. J Immunol 1998, 161: 3400-3407

11  Kim YM, Son K. A nitric oxide production bioassay for interferon-g. J Immunol Methods 1996, 198: 203-209

12  Liu B, Novick D, Kim SH, Rubinstein M. Production of a biologically active human interleukin 18 requires its prior synthesis as PRO-IL-18. Cytokine 2000, 12: 1519-1525

13  Puechler F, Gobel T, Breyer U, Ohnemus A, Staheli P, Kaspers B. A sensitive bioassay for chicken interleukin-18 based on the inducible release of preformed interferon-g. J Immunol Methods 2003, 274: 229-232

14  Sundick RS, Gill-Dixon C. A cloned chicken lymphokine homologous to both mammalian IL-2 and IL-15. J Immunol 1997, 159: 720-725

15  Ohki EC, Tilkins ML, Ciccarone UC, Proce PJ. Improving the transfection efficiency of post-mitotic neurons. J Neurosci Methods 2001, 112: 95-99

16  Lowenthal JW, Digby MR, York JJ. Production of interferon-g by chicken T cells. J Interferon Cytokine Res 1995, 15: 933-938

17  Shen Z, Tie GD, Liu WM, Zhao XX, Duan EK. Expression of transfection eNOS gene in human JAR cells. Acta Zoologica Sinica 2004, 50: 258-262

18  Zhang W, Stephen JB. Development of an internally quenched fluorescent substrate for Escherichia coli leader peptidase. Anal Biochem 1998, 255: 66-73